Muscarinic receptor interaction with full and partial beta-adrenoceptor agonists in the rat colon strip
- PMID: 2897085
- DOI: 10.1007/BF00169240
Muscarinic receptor interaction with full and partial beta-adrenoceptor agonists in the rat colon strip
Abstract
beta-Adrenoceptor agonists inhibit contractile activity in isolated colon strips. In order to demonstrate that beta-adrenoceptors are located at different functional levels within the colon wall, increasing concentrations of muscarinic agonists were used to interact functionally with the beta-adrenoceptor-mediated inhibition of spontaneous colon activity. The effects of the full agonists isoprenaline and terbutaline and of the partial agonist prenalterol were functionally antagonized by carbachol (0.03 and 0.3 mumol/l) and bethanechol (1.3 and 30 mumol/l). This functional antagonism was parallelled by an increase in baseline tension and spontaneous contractile activity of the isolated colon strip. At lower concentrations of carbachol (0.003 and 0.01 mumol/l) or bethanechol (0.03 and 0.3 mumol/l) no effect on the contractile status of the smooth muscle or on the pD2-values of the full agonists was seen. However, at these lower concentrations of muscarinic agonists a marked decrease in the maximal inhibitory response to the partial beta-adrenoceptor agonist prenalterol was demonstrated. The inhibitory response to prenalterol showed a biphasic concentration-response curve. The muscarinic antagonist atropine produced an increase in the maximal response of the high potency component of the concentration-response curve for prenalterol and an increase in the sensitivity to isoprenaline. These results demonstrate the presence of a high cholinergic tone in the colon preparation of a magnitude that clearly reduces the sensitivity to beta-adrenoceptor agonists. The different responses to full and partial beta-adrenoceptor agonists in the presence of increasing concentrations of muscarinic agonists may indicate that beta-adrenoceptors are located on two different functional units within the colon wall.
Similar articles
-
The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.Curr Opin Pharmacol. 2014 Jun;16(100):31-42. doi: 10.1016/j.coph.2014.03.003. Epub 2014 Mar 27. Curr Opin Pharmacol. 2014. PMID: 24682092 Free PMC article. Review.
-
Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.Acta Physiol Scand Suppl. 1985;546:1-39. Acta Physiol Scand Suppl. 1985. PMID: 2869641
-
Characterization of the beta-adrenergic inhibition of motility in cat colon strips.Eur J Pharmacol. 1982 Jan 8;77(1):25-31. doi: 10.1016/0014-2999(82)90530-1. Eur J Pharmacol. 1982. PMID: 6120845
-
Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.Gastroenterology. 1986 Feb;90(2):400-7. doi: 10.1016/0016-5085(86)90939-x. Gastroenterology. 1986. PMID: 2867001
-
[Transition of drug receptor mechanisms].J Smooth Muscle Res. 1992 Apr;28(2):35-54. doi: 10.1540/jsmr.28.35. J Smooth Muscle Res. 1992. PMID: 1327301 Review. Japanese.
Cited by
-
The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.Curr Opin Pharmacol. 2014 Jun;16(100):31-42. doi: 10.1016/j.coph.2014.03.003. Epub 2014 Mar 27. Curr Opin Pharmacol. 2014. PMID: 24682092 Free PMC article. Review.